Antiviral therapy in advanced chronic liver disease due to hepatitis C virus infection: Pilot study
✍ Scribed by RAKESH KUMAR; SUDHEER KUMAR; BARJESH CHANDER SHARMA; JAGDEEP SINGH; SHIV K SARIN
- Book ID
- 108950223
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 97 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with underlying chronic liver disease. Although HAV vaccination is recommended for all patients with chronic hepatitis C virus (HCV) infection, little is known about adherence to these recomm
Twelve of 32 patients lost HBeAg and DNA polymerase from their serum after completing antiviral therapy with interferon and/or adenine arabinoside. Three lost serum HBsAg as well. Loss of corresponding viral markers from hepatic tissue was also seen. There was improvement in symptoms, hepatic tests,
Little is known about the natural history of liver disease in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected subjects under highly active antiretroviral therapy (HAART). The objectives of this study were to obtain information about the mortality, the incidence of hepatic decom